Invivyd, Inc. - Common Stock (IVVD)

As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Invivyd said proceeds will support preparation for a potential VYD2311 launch and broader pipeline development.

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.

Stay updated with the latest market activity on Friday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.

Intrigued by the market activity in the middle of the day on Friday? Uncover the key winners and losers of today's session in our insightful analysis.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Invivyd (IVVD) reported mixed Q3 results, with revenue slightly missing estimates but EPS beating forecasts. The stock surged 9% as investors focused on cost control and progress with its new VYD2311 clinical program.

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.